FDA.reportPublic FDA data

xiidra 50 MG/ML Ophthalmic Solution

RxCUI
1801840
RxNorm name
xiidra 50 MG/ML Ophthalmic Solution
Display name
xiidra 50 MG/ML Ophthalmic Solution
Full name
xiidra 50 MG/ML Ophthalmic Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
XiidraLIFITEGRASTNovartis Pharmaceuticals Corporation8589d376-ac10-4ddb-9c53-2e0c8d5675c42025-08-18Adverse reactionsExact identifier
rxcui: 1801840
XiidraLIFITEGRASTBausch & Lomb Incorporated1a914080-a3c0-44be-b601-0ae3160e77eb2024-11-21Adverse reactionsExact identifier
rxcui: 1801840

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
8589d376-ac10-4ddb-9c53-2e0c8d5675c4xiidra 5 % Ophthalmic SolutionPSN6These highlights do not include all the information needed to use XIIDRA safely and effectively. See full prescribing information for XIIDRA. XIIDRA ® (lifitegrast ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 201620250818
8589d376-ac10-4ddb-9c53-2e0c8d5675c4lifitegrast 50 MG/ML Ophthalmic Solution [Xiidra]SBD6These highlights do not include all the information needed to use XIIDRA safely and effectively. See full prescribing information for XIIDRA. XIIDRA ® (lifitegrast ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 201620250818
8589d376-ac10-4ddb-9c53-2e0c8d5675c4xiidra 50 MG/ML Ophthalmic SolutionSY6These highlights do not include all the information needed to use XIIDRA safely and effectively. See full prescribing information for XIIDRA. XIIDRA ® (lifitegrast ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 201620250818
1a914080-a3c0-44be-b601-0ae3160e77ebxiidra 50 MG/ML Ophthalmic SolutionSY5These highlights do not include all the information needed to use XIIDRA safely and effectively. See full prescribing information for XIIDRA. XIIDRA ® (lifitegrast ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 201620241121
1a914080-a3c0-44be-b601-0ae3160e77eblifitegrast 50 MG/ML Ophthalmic Solution [Xiidra]SBD5These highlights do not include all the information needed to use XIIDRA safely and effectively. See full prescribing information for XIIDRA. XIIDRA ® (lifitegrast ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 201620241121
1a914080-a3c0-44be-b601-0ae3160e77ebxiidra 5 % Ophthalmic SolutionPSN5These highlights do not include all the information needed to use XIIDRA safely and effectively. See full prescribing information for XIIDRA. XIIDRA ® (lifitegrast ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 201620241121